ACP
NBRV
Acuta Capital Partners’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-559,739
| Closed | -$2.82M | – | 71 |
|
|
2018
Q1 | $2.82M | Sell |
559,739
-20,261
| -3% | -$102K | 0.46% | 23 |
|
|
2017
Q4 | $3.47M | Buy |
580,000
+180,000
| +45% | +$1.08M | 0.65% | 20 |
|
|
2017
Q3 | $3.28M | Sell |
400,000
-545,737
| -58% | -$4.47M | 0.59% | 22 |
|
|
2017
Q2 | $9.91M | Buy |
945,737
+268,027
| +40% | +$2.81M | 2.77% | 8 |
|
|
2017
Q1 | $8.13M | Sell |
677,710
-28,673
| -4% | -$344K | 1.93% | 9 |
|
|
2016
Q4 | $4.21M | Buy |
706,383
+122,862
| +21% | +$732K | 1.57% | 19 |
|
|
2016
Q3 | $4.11M | Buy |
583,521
+24,750
| +4% | +$174K | 1.54% | 21 |
|
|
2016
Q2 | $4.19M | Buy |
558,771
+13,799
| +3% | +$103K | 2.01% | 15 |
|
|
2016
Q1 | $4.88M | Buy |
544,972
+132,225
| +32% | +$1.18M | 2.73% | 11 |
|
|
2015
Q4 | $3.97M | Buy |
412,747
+61,486
| +18% | +$592K | 1.9% | 17 |
|
|
2015
Q3 | $3.34M | Buy |
+351,261
| New | +$3.34M | 1.93% | 14 |
|